Amanote Research

Amanote Research

    RegisterSign In

An Update on the Pharmacological Treatment of Nonalcoholic Fatty Liver Disease: Beyond Lifestyle Modifications

Clinical Liver Disease - United Kingdom
doi 10.1002/cld.708
Full Text
Open PDF
Abstract

Available in full text

Categories
Hepatology
Date

April 1, 2018

Authors
Naim AlkhouriAndrea Scott
Publisher

Wiley


Related search

Neurotensin and Nonalcoholic Fatty Liver Disease: Beyond Obesity

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2018English

Nonalcoholic Fatty Liver Disease: Biomarkers Support Decisions Around Pharmacological Intervention

Hepatology
MedicineHepatology
2016English

Nonalcoholic Fatty Liver Disease

Hypertension
Internal Medicine
2020English

Treatment of Nonalcoholic Fatty Liver Disease: Role of AMPK

American Journal of Physiology - Endocrinology and Metabolism
EndocrinologyPhysiologyMetabolismDiabetes
2016English

The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis

Journal of Clinical and Experimental Hepatology
Hepatology
2015English

Nonalcoholic Fatty Liver Disease

Gastroenterology
HepatologyGastroenterology
2002English

Nonalcoholic Fatty Liver Disease in Psoriasis

British Journal of Dermatology
DermatologyMedicine
2018English

Nonalcoholic Fatty Liver Disease in 2020

Gastroenterology
HepatologyGastroenterology
2020English

Ethnicity and Nonalcoholic Fatty Liver Disease

Hepatology
MedicineHepatology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy